🕵️ Humacyte, Inc. ($HUMAW)
SEC insider & ownership activity, last 12 months · CIK 1818382 · every row links its SEC filing
Over the last 12 months insiders sold $7.5M against $60K of open-market buying. Brady W. Dougan sold $3.7M in discretionary trades (Aug). One red-flag 8-K in the window: Delisting notice (3.01), May 4, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $60K (2 lots) · 4 sellers, $7.5M (8 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Brady W. Dougan | 0 | – | 3 | $3.7M | Aug 20, 2025 |
| Laura E. Niklason | 0 | – | 3 | $3.7M | Aug 20, 2025 |
| Sebelius Kathleen | 1 | $50K | 0 | – | May 19, 2026 |
| Shamik J. Parikh | 0 | – | 1 | $41K | May 18, 2026 |
| Dale A. Sander | 0 | – | 1 | $41K | May 18, 2026 |
| Michael T. Constantino | 1 | $10K | 0 | – | May 18, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Fresenius Medical Care Holdings, Inc. | 6.8% | 13D | Jul 10, 2026 | filing ↗ | |
| Fresenius Medical Care Ag | 6.8% | 13D | Jul 10, 2026 | filing ↗ | |
| Blackrock, Inc. | exited | 13G | Jul 28, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Dale A. Sander | $41K | May 18, 2026 | filing ↗ |
| Shamik J. Parikh | $41K | May 18, 2026 | filing ↗ |
| Ayabudge LLC | $937K | Aug 20, 2025 | filing ↗ |
| Ayabudge LLC | $1.8M | Aug 19, 2025 | filing ↗ |
| Ayabudge LLC | $1.0M | Aug 18, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Other events (8.01) | Jun 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 10, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 9, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 9, 2026 | filing ↗ |
| Other events (8.01) | Jun 5, 2026 | filing ↗ |
| Delisting notice (3.01) | May 4, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 21, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 21, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 19, 2026 | filing ↗ |
| Earnings (2.02) | Mar 19, 2026 | filing ↗ |
| Other events (8.01) | Mar 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 19, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 16, 2025 | filing ↗ |
| Material agreement (1.01) | Dec 15, 2025 | filing ↗ |
| New financial obligation (2.03) | Dec 15, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 15, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 15, 2025 | filing ↗ |
| Agreement terminated (1.02) | Dec 15, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 15, 2025 | filing ↗ |
| Agreement terminated (1.02) | Nov 21, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |